BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9035096)

  • 1. Experts attempt to redefine principles for treating HIV.
    Fox JL
    Nat Biotechnol; 1997 Jan; 15(1):14-5. PubMed ID: 9035096
    [No Abstract]   [Full Text] [Related]  

  • 2. Trial volunteers sought.
    Meyer C
    Am J Nurs; 1993 May; 93(5):12. PubMed ID: 8488890
    [No Abstract]   [Full Text] [Related]  

  • 3. Salvage therapy: still more intuition than data.
    Gilden D
    GMHC Treat Issues; 1999 Jan; 13(1):6-12. PubMed ID: 11366112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panels to develop standards for antiviral therapy, viral-load testing.
    AIDS Alert; 1997 Feb; 12(2):13-5. PubMed ID: 11364029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abbott protease inhibitor in combination: sustained viral load drop.
    AIDS Treat News; 1995 Sep; (no 231):4-5. PubMed ID: 11362868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH panel identifies 11 principles for HIV therapy.
    Morey SS
    Am Fam Physician; 1998 Sep; 58(3):783-6. PubMed ID: 9750543
    [No Abstract]   [Full Text] [Related]  

  • 7. Protease inhibitors and beyond: interview with David Feigal, M.D. Interview by John S James.
    Feigal D
    AIDS Treat News; 1995 Mar; (no 219):1-6. PubMed ID: 11362331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical issues regarding the use of antiretroviral therapy for HIV infection.
    Deeks SG
    West J Med; 1998 Feb; 168(2):133-9. PubMed ID: 9499754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AmFAR extols FDA on rapid approval of two protease inhibitors.
    AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune Response and NIH begin pediatric clinical trial of Remune HIV therapy. National Institutes of Health.
    J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):44. PubMed ID: 11363748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitors: implications for HIV research and treatment.
    Churchill SA
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):13-8. PubMed ID: 11363325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical potential of a new HIV protease inhibitor.
    Chapman S; Peterkin J; Quart B; Youle M
    J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):24. PubMed ID: 11362604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIH to study immune system supplement in HIV-infected women.
    Public Health Rep; 1994; 109(3):458-9. PubMed ID: 8190873
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV clinical guidelines.
    N J Med; 1994 Apr; 91(4):203-4. PubMed ID: 8202264
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
    Robinson HL; Weinhold KJ
    J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331
    [No Abstract]   [Full Text] [Related]  

  • 16. New Federal guidelines for the use of antiretroviral agents.
    Proj Inf Perspect; 1997 Jul; (22):3-6. PubMed ID: 11364578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New compound slows HIV replication.
    AIDS Patient Care STDS; 2008 Jun; 22(6):536. PubMed ID: 18680788
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 19. Revised U.S. adult and adolescent antiretroviral treatment guidelines; also revised pediatric guidelines.
    AIDS Treat News; 2003 Nov; (396):4-5. PubMed ID: 14717112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV vector challenges gene therapy oversight.
    Fox JL
    Nat Biotechnol; 1997 Sep; 15(9):832. PubMed ID: 9306390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.